↓ Skip to main content

American Association for Cancer Research

Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells

Overview of attention for article published in Molecular Cancer Therapeutics, August 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent
34 patents

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
156 Mendeley
Title
Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
Published in
Molecular Cancer Therapeutics, August 2011
DOI 10.1158/1535-7163.mct-10-0925
Pubmed ID
Authors

Tongrui Liu, Rami Yacoub, LaTonia D. Taliaferro-Smith, Shi-Yong Sun, Tisheeka R. Graham, Ryan Dolan, Christine Lobo, Mourad Tighiouart, Lily Yang, Amy Adams, Ruth M. O'Regan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 154 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 17%
Student > Ph. D. Student 17 11%
Researcher 12 8%
Student > Master 12 8%
Student > Doctoral Student 5 3%
Other 17 11%
Unknown 67 43%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 22 14%
Biochemistry, Genetics and Molecular Biology 20 13%
Agricultural and Biological Sciences 18 12%
Medicine and Dentistry 8 5%
Engineering 6 4%
Other 14 9%
Unknown 68 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2023.
All research outputs
#2,483,801
of 22,971,207 outputs
Outputs from Molecular Cancer Therapeutics
#307
of 3,870 outputs
Outputs of similar age
#12,393
of 121,138 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#6
of 36 outputs
Altmetric has tracked 22,971,207 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,870 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.